Medical Minutes

Share

Program Content

Activities

  • HER2 and TROP2 in MBC
    MedicalMinute: Selecting Novel HER2- and TROP2-Targeted Therapeutics for Patients With Metastatic Breast Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 09, 2020

    Expires: November 08, 2021

  • Coordinating Testing
    MedicalMinute: Coordinating Care in the Community Setting to Improve Adherence to HER2 Testing Recommendations for MBC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2020

    Expires: December 08, 2021

  • HER2 Testing in MBC
    MedicalMinute: Expert Answers to Key Questions in HER2 Testing in Metastatic Breast Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 10, 2020

    Expires: December 09, 2021

  • HER2/HER3 in GI
    MedicalMinute: Assessment of HER2 Status and Targeting HER2 and HER3 in Gastrointestinal Cancers
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 08, 2021

    Expires: January 07, 2022

  • HER2/HER3/TROP2 ADCs in Lung
    MedicalMinute: Recent Advances With Antibody–Drug Conjugates Targeting HER2, HER3, and TROP2 in Lung Cancers
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 07, 2021

    Expires: May 06, 2022

  • Update: HER2/HER3 in GI
    MedicalMinute: Recent Advances in Targeting HER2 and HER3 in Metastatic Gastrointestinal Cancers
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 27, 2021

    Expires: May 26, 2022

  • Update: HER2/HER3/TROP2 in MBC
    Medical Minute: Recent Advances in HER2-, HER3-, and TROP2-Targeted Therapies for Metastatic Breast Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2021

    Expires: July 06, 2022

  • Pharm: HER2 and TROP2 Agents
    Medical Minute: Recently Approved HER2 and TROP2 Agents: Pharmacist Considerations
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 20, 2021

    Expires: July 19, 2022

Faculty

cover img faculity

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

cover img faculity

Michael F. Press, MD, PhD

Harold E. Lee Chair in Cancer Research
Professor of Pathology
Department of Pathology
University of Southern California, Norris Comprehensive Cancer Center
Los Angeles, California

cover img faculity

Kimberly Allison, MD

Professor of Pathology
Stanford University School of Medicine
Stanford, California

cover img faculity

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
UK Healthcare
Lexington, Kentucky

cover img faculity

Daniel Catenacci, MD

Assistant Professor of Medicine
Division of Hematology-Oncology
Department of Medicine
University of Chicago
Chicago, Illinois

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Ian E. Krop, MD, PhD

Associate Professor of Medicine
Harvard Medical School
Associate Chief, Division of Breast Oncology
Breast Oncology Program
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Manish A. Shah, MD

Assistant Member, Department of Medicine, Gastrointestinal Oncology
Memorial Sloan-Kettering Cancer Center
Attending Physician, Department of Medicine, Division of Solidy Tumor Oncology
Memorial Hospital
New York, New York

Provided by

ProCE Banner

Supporters

Daiichi Sankyo, Inc.